European HIV vaccine research

Gus Cairns
Published: 21 January 2013

As part of our European HIV prevention work, NAM is collaborating with AVAC to provide a series of webinars (conference calls with accompanying slides) to train and inform prevention advocates and anyone interested in the newest developments in HIV prevention technology in Europe. 

The first webinar is entitled:

European contributions to the search for an HIV vaccine 

This webinar will examine current European efforts in HIV vaccine research and will provide an opportunity for advocates to ask questions of a range of expert speakers. The webinar will be conducted in English.

Time and date: 2pm UK time (GMT), Tuesday 29 January 2013

This 90-minute webinar will provide advocates with an overview of European efforts to develop an HIV vaccine through national and EU-funded programmes. The presentations will be followed by a question and answer session with our expert speakers.


The webinar will by feature presentations by:

Dr Gabriella Scarlatti – The ANRS and EU-funded efforts

Dr Gabriella Scarlatti is on the faculty at the San Raffaele Scientific Institute, Milan, Italy and Head of the Viral Evolution and Transmission Unit there. She recently headed the EU-funded NeutNet programme, a group aimed at standardising methods for the measurement of neutralising antibodies to HIV for use in human clinical trials of candidate HIV vaccines.

Dr Eric Sandström – Karolinska Institutet funded efforts

Dr Eric Sandström is on the faculty at the South Hospital, Karolinska Institutet. Karolinska Institutet studies the safety of preventive HIV vaccines and the effect of therapeutic vaccines as an addition to antiretroviral therapy. Dr Sangstrom has been the investigator on vaccine trials in Tanzania.

Kevin Fisher – European investment in HIV vaccines to date

Kevin Fisher is director of the HIV Vaccines and Microbicides Resource Tracking Working Group, which includes UNAIDS and IAVI, and has tracked European investment in HIV vaccines since 2000.

The discussion will be introduced and moderated by Rebekah Webb. Rebekah is a freelance consultant specialising in advocacy and resource mobilisation for global health. She provides ongoing support to the work of AVAC in Europe. From 2003 until 2009, Rebekah was the European Co-ordinator of the Global Campaign for Microbicides, working with civil society organisations and networks in 15 countries.

European advocates interested in learning more about vaccines and the role that Europe is playing in the global search for an HIV vaccine are encouraged to join this webinar and to email questions in advance to During the event, participants will be encouraged to ask questions via telephone.

For more information

Please click here to register for the webinar and to receive joining instructions.

You can find out more about HIV vaccine research in our online resource Preventing HIV

For regular updates on HIV prevention in Europe, sign up (free) for our monthly HIV prevention news: Europe email bulletin. It is available in English, French, Spanish, Portuguese and Russian.

The following webinar, on Tuesday 26 February, will examine European microbicide research.

Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.